Header Logo

Connection

RAJYALAKSHMI LUTHRA to Ipilimumab

Back to Details
This is a "connection" page, showing publications RAJYALAKSHMI LUTHRA has written about Ipilimumab.
RAJYALAKSHMI LUTHRA
Connection Strength
0.041
Ipilimumab
  1. Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. Clin Cancer Res. 2024 Apr 15; 30(8):1655-1668.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.